Oncoinvent ASA (BRRGD) Stock Statistics & Valuation Metrics

Oncoinvent ASA has a market cap or net worth of $18.98M. The enterprise value is -$11.35M.

Oncoinvent ASA has 4,478,411 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oncoinvent ASA’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -121.57%.

The current PE Ratio of Oncoinvent ASA is ―. Oncoinvent ASA’s PEG ratio is ―.

In the last 12 months, Oncoinvent ASA had revenue of 848.00K and earned -139.28M in profits. Earnings per share was -3.95.

In the last 12 months, operating cash flow was -137.83M and capital expenditures 0.00, giving a free cash flow of -137.83M billion.

Oncoinvent ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Oncoinvent ASA upcoming earnings date is Feb 19, 2026, TBA (Confirmed).

Oncoinvent ASA as a current ratio of 4.79, with Debt / Equity ratio of 0.00%

In the past 12 months, Oncoinvent ASA has paid 0.00 in taxes.

Oncoinvent ASA EV to EBITDA ratio is -214.10, with an EV/FCF ratio of -187.40.

Oncoinvent ASA has $65.92M in cash and marketable securities with $818.00K in debt, giving a net cash position of $65.92M billion.

Gross margin is 98.06%, with operating margin of -17834.20%, and net profit margin of -16424.76%.

The average price target for Oncoinvent ASA is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy